July 31 (Reuters) - Medadvisor Ltd MDR.AX:
MDR 4Q FY25 QUARTERLY ACTIVITY REPORT AND 4C
4Q FY25 OPERATING REVENUE OF A$18.6 MILLION
BOARD CONSIDERING SALE OF US BUSINESS
FY25 GROSS PROFIT DOWN 27.9% ON PCP TO A$53.5 MILLION
SEES FY25 EBITDA LOSS A$6.5 -A$7.3 MILLION
SEES FY25 REVENUE A$88.0 MILLION
Further company coverage: MDR.AX
((Reuters.Briefs@thomsonreuters.com;))